Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 15, 2014 (Vol. 34, No. 8)

NEBioCalculator

URL:nebiocalculator.neb.com
  • Clean site design
  • Not much content

In today’s world of tablets and smartphones, the NEBioCalculator may at first seem like it belongs under the “app review” section of this column. However, let’s not forget that bench scientists actually use their computers once in a while, too… The NEBioCalculator, an online tool from (you guessed it) New England Biolabs, provides a simple web interface for scientists to access a number of calculators relevant to molecular biology experiments. These include four DNA calculators (ligation calculator and three unit conversion calculators for double-stranded DNA), two RNA calculators (mass-to-moles and moles-to-mass conversions), and three general calculators (concentration from optical density, dilution calculator, and molarity calculator). The site is sleekly and minimally designed, thereby facilitating quick use of the calculators. There may not be a great depth of content here, but the tools that are on the site are quite useful.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »